AEPCX
Price
$59.44
Change
+$0.30 (+0.51%)
Updated
Sep 5 closing price
Net Assets
133.49B
FCPCX
Price
$29.33
Change
+$0.12 (+0.41%)
Updated
Sep 5 closing price
Net Assets
15.44B
Interact to see
Advertisement

AEPCX vs FCPCX

Header iconAEPCX vs FCPCX Comparison
Open Charts AEPCX vs FCPCXBanner chart's image
American Funds EUPAC C
Price$59.44
Change+$0.30 (+0.51%)
VolumeN/A
Net Assets133.49B
Fidelity Advisor Intl Cap App C
Price$29.33
Change+$0.12 (+0.41%)
VolumeN/A
Net Assets15.44B
AEPCX vs FCPCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. FCPCX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and FCPCX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. FCPCX (15.4B). AEPCX pays higher dividends than FCPCX: AEPCX (0.16) vs FCPCX (0.00). AEPCX was incepted earlier than FCPCX: AEPCX (25 years) vs FCPCX (28 years). FCPCX (1.87) is less costly to investors than AEPCX (1.57). FCPCX is a more actively managed with annual turnover of: 63.00 vs. AEPCX (35.00). FCPCX has a lower initial minimum investment than AEPCX: FCPCX (0) vs AEPCX (250). FCPCX annual gain was more profitable for investors over the last year : 14.97 vs. AEPCX (7.59). FCPCX return over 5 years is better than : 38.02 vs. AEPCX (7.78).
AEPCXFCPCXAEPCX / FCPCX
Total Expense Ratio1.571.8784%
Annual Report Gross Expense Ratio1.571.8784%
Fund Existence25 years28 years-
Gain YTD15.03816.57491%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets133B15.4B864%
Annual Yield % from dividends0.160.00-
Returns for 1 year7.5914.9751%
Returns for 3 years32.6562.1353%
Returns for 5 years7.7838.0220%
Returns for 10 years34.34123.2128%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.270.03
+2.42%
Pacific Biosciences of California
VVX56.681.23
+2.22%
V2X
GANX1.760.02
+1.15%
Gain Therapeutics
LINE40.590.13
+0.32%
Lineage Inc.
QVCGP6.980.02
+0.29%
QVC Group Inc.